Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Top Cited Papers
- 2 November 2006
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 48 (12) , 2584-2591
- https://doi.org/10.1016/j.jacc.2006.10.026
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting StentsCirculation, 2006
- Coronary-Artery StentsNew England Journal of Medicine, 2006
- Coronary syndromes following aspirin withdrawalJournal of the American College of Cardiology, 2005
- Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary SyndromesCirculation, 2004
- Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialThe Lancet, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel ResistanceCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery LesionsCirculation, 2003
- Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial InfarctionEuropean Heart Journal, 2000